期刊文献+

miR-19对肺腺癌A549细胞株迁移功能的影响 被引量:5

Effect of miR-19 on migration ability of lung adenocarcinoma cell line A549-Luc
下载PDF
导出
摘要 目的:探讨miR-19对肺腺癌A549细胞株迁移能力的作用。方法:运用qRT-PCR检测miR-19在肺上皮细胞株BEAS-2B和肺腺癌A549-Luc细胞株中的表达;建立稳定过表达miR-19的A549-Luc肺癌细胞株;qRT-PCR鉴定稳定细胞株A549/RFP+/H2B和A549/RFP+/m19中miR-19的表达水平;观察其形态变化及Transwell小室细胞迁移实验检测细胞迁移能力变化。结果:miR-19在BEAS-2B及A549-Luc细胞中的表达差异具有显著性(t=-20.954,P<0.001)。成功建立了稳定过表达miR-19的肺腺癌细胞株A549/RFP+/m19;观察发现A549/RFP+/m19细胞形态发生变化,且与空载A549/RFP+/H2B细胞相比,A549/RFP+/m19细胞迁移能力增强(P<0.001)。结论:miR-19可使肺腺癌A549-Luc细胞迁移能力增强。 Objective To investigate the effects of miR-19 on the migration ability of lung adenocarcinoma cell line A549. Methods The expressions of miR-19 in lung epithelial cell line BEAS-2B and lung adenocarcinoma cell line A549-Luc were detected by qRT-PCR.The A549-Luc cell line which over-expressed miR-19 was established. The expression levels of miR-19 in A549/RFP+/H2B and A549/RFP+/m19 were identified by qRT-PCR. The morphology of A549/RFP+/m19 was observed,and the migration ability of A549/RFP+/mI9 was detected by transwell migration assay. Results The expression levels of miR-19 differed significantly between BEAS-2B cells and A549-Luc cells (t = -20.954, P 〈 0.001 ). The lung adenocarcinoma cell line A549/RFP+/ m19 which over-expressed miR-19 was successfully established. Changes in A549/RFP+/m19 cell morphology were found. As compared with A549/RFP+/H2B ceils, A549/RFP+/m19 had an increased migration ability (P 〈 0.01 ). Conclusions miR-19 enhances the migration ability of lung adenocarcinoma A549-Luc cells.
出处 《实用医学杂志》 CAS 北大核心 2014年第13期2031-2034,共4页 The Journal of Practical Medicine
基金 国家自然科学基金青年科学基金项目(编号:81302965) 广东省自然科学基金博士启动项目(编号:S2013040014341) 广东省医学科研课题(编号:B2013061)
关键词 肺腺癌 miR-19 迁移 Lung adenocarcinoma miR-19 Migration
  • 相关文献

参考文献17

  • 1郝捷.2012中国肿瘤登记年报[M].北京:军事医学科学出版社.2012.
  • 2Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice andclinical trials [J]. J Clin Oncol, 2013,31(8) :992-1001.
  • 3He L, T homson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene [ J ]. Nature, 2005, 435 (7043) : 828-833.
  • 4Olive V, Bennett MJ, Walker JC, et al. miR-19 is a key oncogenic component of mir- 17-92 [ J ]. Genes Dev, 2009,23 (24) : 2839-2849.
  • 5Mu P, Han YC, Betel D, et al. Genetic dissection of the miR- 17-92 cluster of microRNAs in Myc-induced B-cell lymp boreas [ J ]. Genes Dev, 2009,23 (24) : 2806-2811.
  • 6Bouyssou JM, Manier S, Huynh D, et al. Regulation of mieroRNAs in cancer metastasis [J]. Bioe him Biop hys Aeta, 2014,1845 (2) : 255-265.
  • 7Wang H, Zhu Y, Zhao M, et al. miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin betal and matrix metalloproteinase2 (MMP2) [J]. PLoS One,2013,8 (8) :e70192.
  • 8Liu N, Tang LL, Sun Y, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasop haryngeal carcinoma [J]. Cancer Lett,2013,329 (2) : 181-188.
  • 9Kumarswamy R, Mudduluru G, Ceppi P, et al. MicroRNA-30a in hibits epit helial-to-mesenc hymal transition by targeting Snail and is downregulated in non-small cell lung cancer [J]. Int J Cancer, 2012,130 (9) : 2044-2053.
  • 10Zhong M, Bian Z, Wu Z. miR-30a suppresses cell migration and invasion t hroug h downregulation of PIK3CD in colorectalcarcinoma [J]. Cell Physiol Biochem,2013,31 (2-3) : 209- 218.

共引文献41

同被引文献59

  • 1金高娃,王华庆,胡晟,高艳梅.LncRNA TCF7通过调控miR-29和激活JAK/STAT2信号通路促进肺癌细胞的恶性生物学行为研究[J].国际生物医学工程杂志,2018,41(6):527-533. 被引量:1
  • 2郝捷.2012中国肿瘤登记年报[M].北京:军事医学科学出版社.2012.
  • 3邹享珍.慢性乙肝患者血清NO与肝纤维化关系探讨[J].河北医学,2007,13(5):595-597. 被引量:2
  • 4金顺姬.五味子的保肝作用研究[J].长春中医药大学学报,2007,23(6):28-28. 被引量:20
  • 5Chan BA, Hughes BG. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future[J] . Transl Lung Cancer Res,2015 ,4(1) :36 -54.
  • 6Lin Q, Chen T, Lin Q, et aI. Serum miR -19 a expression correlates with worse prognosis of patients with non-small cell lung cancer[J].J Surg Oncol,2013,107(7) :767 -771.
  • 7Elinav E, Nowarski R, Thaiss CA, et aI. Inflammation-induced cancer: crosstaIk between tumours, immune cells and microorganisms[J]. Nat Rev Cancer ,2013 ,13 (11 ) : 759 -771.
  • 8Barlesi F , Scherpereel A, Gorbunova V, et aI. Maintenance bevacizumab - pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmaIl-celi lung cancer: updated survivaI analysis of the AV APERL (M022089) randomized phase III triaI[J]. Ann Oncol,2014,25(5) :1044 -1052.
  • 9Molina - Pinelo S,Gutierrez G,Pastor MD,et aI. MicroRNA-dependent regulation of transcription in non-small cell lung cancer[J]. PLoS One,2014 ,9(3) :e90524.
  • 10Krysan K,Kusko R,Grogan T,et aI. PGE2-driven expression ofcMyc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC[J]. Mol Cancer Res,2014,12(5) :765 -774.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部